CV Sciences, Inc.
CVSI
$0.03
$0.00051.70%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 41.99% | -177.18% | -443.77% | -1,741.56% | -166.89% |
| Total Depreciation and Amortization | 40.53% | 41.11% | 29.54% | 56.80% | -29.78% |
| Total Amortization of Deferred Charges | 2,883.33% | 86.61% | -68.80% | -100.00% | -98.76% |
| Total Other Non-Cash Items | -114.81% | 107.20% | 114.91% | 117.35% | 122.45% |
| Change in Net Operating Assets | -75.64% | -88.56% | -83.90% | -82.30% | 2.78% |
| Cash from Operations | -155.79% | -138.22% | -131.47% | -134.55% | 243.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 93.59% | 93.59% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 56.41% | 82.05% | -- | -- | -- |
| Total Debt Issued | -- | -- | 91.90% | -- | -- |
| Total Debt Repaid | -108.40% | 37.96% | 71.83% | 89.93% | 75.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 99.19% | -- | -- |
| Cash from Financing | 198.93% | 102.30% | 115.00% | 79.16% | 45.14% |
| Foreign Exchange rate Adjustments | -500.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 388.46% | -222.24% | -231.75% | -310.59% | 96.99% |